The IngenioRx P&T Committee
All clinical criteria are developed to help guide clinically appropriate use of drugs and therapies and are reviewed and approved by the IngenioRx Pharmacy and Therapeutics (P&T) Committee. The P&T Committee is an independent and external committee including practicing physicians, pharmacists, and clinicians from leading academic medical centers and clinical practices with expertise in evidence-based medicine. All major clinical specialties are represented. The P&T Committee normally meets four times a year to review evidence related to the safety and efficacy of drugs, biologics, and devices.
The P&T reviews include, but are not limited to: FDA approved indications, information provided in major peer reviewed publications, recommendations by recognized experts or leading medical centers, and treatment guidelines. Once efficacy, safety, health outcomes, and comparison to other drugs are known, the clinical value is determined for each drug and is used to inform formulary status, tiering, prior authorization, and step therapy decisions.
View our clinical criteria. If you have questions or feedback, please email us.